Clinical kinetics of 1,4-dihydroxy-5,8-bis [[2- [(2-hydroxyethyl)amino ]ethyl] amino]-9,10-anthracenedione
โ Scribed by Savaraj, Niramol; Lu, Katherine; Valdivieso, Manuel; Burgess, Michael; Umsawasdi, Theera; Benjamin, Robert S; Loo, Ti Li
- Book ID
- 109843187
- Publisher
- Nature Publishing Group
- Year
- 1982
- Tongue
- English
- Weight
- 281 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0009-9236
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
D HA Q, a new antitumor agent, has been selected for clinical trial on the basis of its activity against a number of transplantable rodent tumors. In anticipation of the clinical trial of this agent, the pharmacology of DHAQ was studied in beagles by high-pressure liquid chromatographic and radioche
An oxygen analog of the antineoplastic anthraquinone, 1,4-dihydroxy-5,8-bis[ [2-(2-hydroxyethyl)amino]ethyl)amino -9,lO -anthracenedione, was synthesized. This compound, 1,4-dihydroxy-5,8bis[ [2-(2-hydroxyethoxy)ethyI]amino] -9,10-anthracenedione, was found to be inactive against P-388 lymphocytic l